Nearly 1 in 5 women struggle with heavy menstrual bleeding. Generally speaking, periods are considered “heavy” if there is enough bleeding to soak through your protection every hour for several hours in a row, or if your period lasts longer than 7 days. Heavy periods can be very stressful, and can interfere with nearly every aspect of daily life.
Right now, doctors at select women’s health centers in the U.S. are accepting participants for the EASE Clinical Trial. The trial is for the Minitouch System – an investigational, non-surgical device designed to reduce heavy menstrual bleeding.
One treatment option for heavy menstrual bleeding is endometrial ablation. This procedure works by removing (ablating) the inner lining of the uterus, known as the endometrium – which can reduce or even stop menstrual bleeding in some women. Different kinds of ablation treatments have been available to women for many years.
The purpose of the EASE Clinical Trial is to evaluate an investigational endometrial ablation device called the Minitouch System. The Minitouch System is designed to remove the inner lining of the uterus by using controlled microwave (heat) energy. The Minitouch procedure can be performed in the doctor’s office and does not usually require sedation or general anesthesia.
If you qualify and choose to participate in the EASE Clinical Trial, you will receive treatment with the Minitouch System at no cost. As part of the study you will be asked to return to your study doctor’s office 6 times over a 3-year period to track your results. Some or all of these visits may be conducted via telemedicine visit (phone, video, or virtual office). You will also be compensated for your time to participate in these follow-up visits.
See If You Qualify
To see if you might qualify, and to get connected with your local study centre to learn more, please take the questionnaire below.